A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.

NCT Number	NCT07421895
Lead Sponsor	The Third Xiangya Hospital of Central South University Collaborators: Changsha Hospital for Maternal and Child Health Care, ZhuZhou Central Hospital, Xiangtan Central Hospital, Xiangtan Hospital for Maternal and Child Health Care, Yiyang Hospital for Maternal and Child Health Care, The First People's Hospital of YueYang, The First People's Hospital of Changde City, The First Affiliated Hospital of Shaoyang University, Hunan University of Medicine General Hospital, Hengyang Central Hospital, Chenzhou Hospital for Maternal and Child Health Care, Yongzhou Center Hospital, Hunan Provincial People's Hospital, Changsha Maternal and Child Health Hospital, Liuyang People's Hospital
Conditions	Retained Products of Conception, RPOC
Enrollment	600 participants
Start Date	2022-06-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2032-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-19